Bas Oldenburg

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 158 publications

Transfer of faeces in ulcerative colitis 2: improving efficacy - study protocol for a multicentre randomised controlled trial (TURN2 study).

Transfer of faeces in ulcerative colitis 2: improving efficacy - study protocol for a multicentre randomised controlled trial (TURN2 study).

Journal: BMJ open

Published: May 05, 2026

Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Journal: Communications medicine

Published: January 23, 2026

Clonal overlap and convergent clustering of T cell receptor signatures in Crohn's disease in monozygotic twins.

Clonal overlap and convergent clustering of T cell receptor signatures in Crohn's disease in monozygotic twins.

Journal: Inflammatory bowel diseases

Published: January 07, 2026

Univariate- and machine learning-based plasma metabolite signature differentiates PSC-IBD from IBD and is predicted to be driven by gut microbial changes.

Univariate- and machine learning-based plasma metabolite signature differentiates PSC-IBD from IBD and is predicted to be driven by gut microbial changes.

Journal: Metabolomics : Official journal of the Metabolomic Society

Published: December 22, 2025

AIRRWAS integrates TCR-microbiome data to reveal how the gut microbiome shapes the circulating and mucosal T cell repertoire.

AIRRWAS integrates TCR-microbiome data to reveal how the gut microbiome shapes the circulating and mucosal T cell repertoire.

Journal: Cell reports

Published: December 11, 2025

Prospective real-world experience with risankizumab in difficult-to-treat Crohn's disease: results from the Dutch Initiative on Crohn and Colitis Registry.

Prospective real-world experience with risankizumab in difficult-to-treat Crohn's disease: results from the Dutch Initiative on Crohn and Colitis Registry.

Journal: Inflammatory bowel diseases

Published: October 03, 2025

Mucosal kinase activity and inflammatory profiles in inflammatory bowel disease, and in relation to tofacitinib response.

Mucosal kinase activity and inflammatory profiles in inflammatory bowel disease, and in relation to tofacitinib response.

Journal: Journal of Crohn's & colitis

Published: September 23, 2025

Distinct Effects of Autologous Hematopoietic Stem Cell Transplantation on T Cell Composition and Profile in Refractory Crohn's Disease.

Distinct Effects of Autologous Hematopoietic Stem Cell Transplantation on T Cell Composition and Profile in Refractory Crohn's Disease.

Journal: Inflammatory bowel diseases

Published: September 05, 2025

Mapping the impact of JAK inhibitors at a cellular resolution in inflammatory bowel disease.

Mapping the impact of JAK inhibitors at a cellular resolution in inflammatory bowel disease.

Journal: Cellular and molecular gastroenterology and hepatology

Published: July 22, 2025

Calculation of Compound Intake Levels Using Integrated Food Compound Databases and Food Intake Data.

Calculation of Compound Intake Levels Using Integrated Food Compound Databases and Food Intake Data.

Journal: Current developments in nutrition

Published: July 11, 2025

Reply to 'Critical appraisal of the HELIOS study on surveillance in IBD patients'.

Reply to 'Critical appraisal of the HELIOS study on surveillance in IBD patients'.

Journal: Gut

Published: May 27, 2025

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events.

Journal: Communications medicine

Published: March 05, 2025

Showing 1-12 of 158

Last Updated: 09/26/2026